ClinVar Miner

Submissions for variant NM_003742.4(ABCB11):c.1441G>A (p.Val481Met)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002663931 SCV003523145 likely benign not provided 2024-07-08 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003900872 SCV004709240 uncertain significance ABCB11-related disorder 2023-12-14 no assertion criteria provided clinical testing The ABCB11 c.1441G>A variant is predicted to result in the amino acid substitution p.Val481Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.052% of alleles in individuals of East Asian descent in gnomAD and has been interpreted in ClinVar as likely benign (https://preview.ncbi.nlm.nih.gov/clinvar/variation/2201827/). Of note, a different variant impacting the same amino acid (p.Val481Glu) has been reported in the biallelic state in a patient with bile salt export pump (BSEP) deficiency (Patient 36 in Strautnieks et al. 2008. PubMed ID: 18395098) and in patients from a cholestasis cohort (Patients 22-24 in Table S3, Hertel. 2021. PubMed ID: 34016879). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.